Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
Harvard Business School
Mallinckrodt
Dow

Last Updated: September 26, 2022

Details for New Drug Application (NDA): 019855


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


NDA 019855 describes ELIMITE, which is a drug marketed by Aurobindo Pharma Usa and is included in one NDA. Additional details are available on the ELIMITE profile page.

The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the permethrin profile page.
Summary for 019855
Tradename:ELIMITE
Applicant:Aurobindo Pharma Usa
Ingredient:permethrin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019855

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength5%
Approval Date:Aug 25, 1989TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Moodys
McKinsey
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.